VYNE Therapeutics Inc. deeply regrets to announced that Mr. Rex Bright passed away on January 11, 2022. Mr. Bright was a director of the company and also served as the Chair of the Company's Compensation Committee and a member of the Company's Audit Committee. On January 14, 2022, the Board appointed Patrick LePore to serve as a member of the Company's Audit Committee and Elisabeth Sandoval to serve as chairperson of the Compensation Committee.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.62 USD | +4.80% | +4.80% | +12.45% |
04-04 | Transcript : VYNE Therapeutics Inc. - Special Call | |
02-29 | VYNE Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.45% | 36.94M | |
+26.08% | 662B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
-3.40% | 157B |
- Stock Market
- Equities
- VYNE Stock
- News VYNE Therapeutics Inc.
- VYNE Therapeutics Inc. Announces Board Changes